Permission-based content marketing is built on a foundation of trust and reciprocity. The silent conversation goes something like this.
Potential Customer: I have a challenge for which I need to find a solution. Based on the description of your content, you seem to understand at least part of my challenge and it seems as though via your research, expertise and/or technology development you might be able to help me to solve at least part of my problem. I am going to trust that our exchange will be equitable, so I going to give you my contact information and answer your question or two. In exchange, I trust that I will be granted access to a rich piece of content that is inline with the quantity and value of the information I gave you.
Solution Provider: I ultimately need to sell my product or service and I believe that a great way to begin creating opportunities is to share my expertise and solutions-oriented information with customers and potential customers who have a problem I can help to solve. If I can solve a problem, I will have a solid opportunity to build or further develop a mutually beneficial client relationship. Because I understand that this opportunity creation tactic is built on mutual trust and respect, I will under promise and over deliver. The content I provide will be even more valuable than my customer or potential customer believes that it will be
prior to registering to access my content.
Potential Customer: I also trust that this solutions provider will respect my by providing information that is in-line with my needs, not spamming me and not sharing my contact information with other people without my permission. If that trust is broken, it does not bode will for our potential relationship.
I have a great number of concerns relating to this issue with the pharmaceutical manufacturing space of the b2b media industry. Trust is being broken; short cuts are being taken that ultimately are not good for anyone within the marketing value chain.
A series of three to five posts sharing thoughts, best practices and ultimately solutions on this topic will be posted during the next few weeks. Stay tuned!
Potential Customer: I have a challenge for which I need to find a solution. Based on the description of your content, you seem to understand at least part of my challenge and it seems as though via your research, expertise and/or technology development you might be able to help me to solve at least part of my problem. I am going to trust that our exchange will be equitable, so I going to give you my contact information and answer your question or two. In exchange, I trust that I will be granted access to a rich piece of content that is inline with the quantity and value of the information I gave you.
Solution Provider: I ultimately need to sell my product or service and I believe that a great way to begin creating opportunities is to share my expertise and solutions-oriented information with customers and potential customers who have a problem I can help to solve. If I can solve a problem, I will have a solid opportunity to build or further develop a mutually beneficial client relationship. Because I understand that this opportunity creation tactic is built on mutual trust and respect, I will under promise and over deliver. The content I provide will be even more valuable than my customer or potential customer believes that it will be
prior to registering to access my content.
Potential Customer: I also trust that this solutions provider will respect my by providing information that is in-line with my needs, not spamming me and not sharing my contact information with other people without my permission. If that trust is broken, it does not bode will for our potential relationship.
I have a great number of concerns relating to this issue with the pharmaceutical manufacturing space of the b2b media industry. Trust is being broken; short cuts are being taken that ultimately are not good for anyone within the marketing value chain.
A series of three to five posts sharing thoughts, best practices and ultimately solutions on this topic will be posted during the next few weeks. Stay tuned!
This post first appeared on Pharmaceutical Industry B2B Marketing, please read the originial post: here
